Eli Lilly has agreed to acquire Scorpion Therapeutics’ breast cancer treatment program for up to $2.5 billion in cash. The drugmaker said Monday it is acquiring Scorpion and its STX-478 program ...
Includes reviews of Covert Hutto from DealerRater. Want to share your experience with this dealership? Everything went smooth just had to wait for couple of hours for documentation work and wish ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback